{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:30:47Z","timestamp":1790728247175,"version":"4.1.0"},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Middle East Afr J Ophthalmol"],"published-print":{"date-parts":[[2013]]},"DOI":"10.4103\/0974-9233.106387","type":"journal-article","created":{"date-parts":[[2013,1,23]],"date-time":"2013-01-23T05:20:19Z","timestamp":1358918419000},"page":"51","source":"Crossref","is-referenced-by-count":18,"title":["Early vitreous hemorrhage after vitrectomy with preoperative intravitreal bevacizumab for proliferative diabetic retinopathy"],"prefix":"10.4103","volume":"20","author":[{"given":"Tatsuhiko","family":"Sato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shin-ichi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Bando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihide","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Emi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0974-9233.106387-1","first-page":"301","volume-title":"Dissemination of the published results of an important clinical trial: An analysis of the citing literature","author":"Dunn","year":"1981","journal-title":"Bull Med Libr Assoc"},{"key":"key-10.4103\/0974-9233.106387-2","first-page":"122","volume-title":"Perspectives on diabetic retinopathy","author":"Aiello","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0974-9233.106387-3","first-page":"492","volume-title":"Diabetic Retinopathy Vitrectomy Study (DRVS) report #1","author":"Two-year","year":"1985","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.106387-4","first-page":"581","volume-title":"Vascular endothelial growth factor: Basic science and clinical progress","author":"Ferrara","year":"2004","journal-title":"Endocr Rev"},{"key":"key-10.4103\/0974-9233.106387-5","first-page":"111","volume-title":"The role of vascular endothelial growth factor in ocular health and disease","author":"Adamis","year":"2005","journal-title":"Retina"},{"key":"key-10.4103\/0974-9233.106387-6","first-page":"1480","volume-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders","author":"Aiello","year":"1994","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0974-9233.106387-7","first-page":"1198","volume-title":"Genentech discloses safety concerns over Avastin","author":"Ratner","year":"2004","journal-title":"Nat Biotechnol"},{"key":"key-10.4103\/0974-9233.106387-8","first-page":"363","volume-title":"Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration","author":"Avery","year":"2006","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.106387-9","first-page":"279","volume-title":"Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: A short-term study","author":"Iturralde","year":"2006","journal-title":"Retina"},{"key":"key-10.4103\/0974-9233.106387-10","first-page":"419","volume-title":"Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion","author":"Rabena","year":"2007","journal-title":"Retina"},{"key":"key-10.4103\/0974-9233.106387-11","first-page":"1450","volume-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: A pilot study","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-9233.106387-12","first-page":"837","volume-title":"Injection of intravitreal bevacizumab (Avastin) as a preoperative adjunct before vitrectomy surgery in the treatment of severe proliferative diabetic retinopathy (PDR)","author":"Rizzo","year":"2008","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/0974-9233.106387-13","first-page":"688","volume-title":"Intraoperative bleeding during vitrectomy for diabetic tractional retinal detachment with versus without preoperative intravitreal bevacizumab (IBeTra study)","author":"da","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0974-9233.106387-14","first-page":"1943","volume-title":"Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: A randomized clinical trial","author":"Ahmadieh","year":"2009","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.106387-15","first-page":"926","volume-title":"Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin)","author":"Lo","year":"2009","journal-title":"Retina"},{"key":"key-10.4103\/0974-9233.106387-16","first-page":"927","volume-title":"Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment","author":"Oshima","year":"2009","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.106387-17","first-page":"151","volume-title":"Preoperative disinfection of the conjunctival sac with antibiotics and iodine compounds: A prospective randomized multicenter study","author":"Inoue","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"key-10.4103\/0974-9233.106387-18","first-page":"635","volume-title":"Increased bactericidal activity of dilute preparations of povidone-iodine solutions","author":"Berkelman","year":"1982","journal-title":"J Clin Microbiol"},{"key":"key-10.4103\/0974-9233.106387-19","first-page":"855","volume-title":"Pharmacokinetics of intravitreal bevacizumab (Avastin)","author":"Bakri","year":"2007","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.106387-20","first-page":"1880","volume-title":"Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy","author":"Itakura","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0974-9233.106387-21","first-page":"2218","volume-title":"The effect of adjunctive intravitreal bevacizumab for preventing postvitrectomy hemorrhage in proliferative diabetic retinopathy","author":"Ahn","year":"2011","journal-title":"Ophthalmology"}],"container-title":["Middle East African Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:02:45Z","timestamp":1786633365000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0974-9233.106387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013]]}},"alternative-id":["106387"],"URL":"https:\/\/doi.org\/10.4103\/0974-9233.106387","relation":{},"ISSN":["0974-9233"],"issn-type":[{"value":"0974-9233","type":"print"}],"subject":[],"published":{"date-parts":[[2013]]}}}